FP
FRIEDMAN PAUL A
Director
BoardM
Insider track record
Board DirectorNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by FRIEDMAN PAUL A, Director. Insider active across 3 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 11 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €422k. History available since 20 May 2021. The latest transaction was disclosed on 18 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
1,400 shares@ US$9.450.8% of flowCommon StockSEC:0001628280-25-035580:0
1,400 shares@ US$350.031429.9% of flowCommon StockSEC:0001628280-25-035580:1
714 shares0Common StockSEC:0000950170-24-078748:0
26,270 shares@ US$9.4516.2% of flowCommon StockSEC:0000950170-24-043502:0
27,407 shares@ US$9.4517.0% of flowCommon StockSEC:0000899243-24-000265:0
2,254 shares@ US$243.9236.1% of flowCommon StockSEC:0000950170-24-005297:0
26,668 shares0Common StockSEC:0000899243-23-002095:0
12,840 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000075
12,840 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000075:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000046:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000046
About FRIEDMAN PAUL A
Paul A. Friedman is a Board Member at ALEXION PHARMACEUTICALS, INC. He plays a key role in overseeing the company's operations and in developing long-term strategies. His expertise in corporate governance is essential to ensure that decisions made align with shareholder interests.